Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012). Breast Cancer Res Treat. 2010 Jan; 119(2):391-8.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Colony-Forming Units Assay
Cyclophosphamide
Doxorubicin
Female
Gene Expression Regulation, Leukemic
Genetic Predisposition to Disease
Genetic Testing
Hematopoiesis
Hematopoietic Stem Cells
Humans
Leukemia, Myeloid
Microsatellite Instability
Middle Aged
Pilot Projects
Predictive Value of Tests
Prospective Studies
Risk Assessment
Risk Factors
Time Factors

authors with profiles

Wendy Stock